Regulatory affairs for medical devices is fundamentally expert document work: writing and reviewing technical documentation, building clinical evaluations, planning submissions. None of that depends on you and your consultant sharing geography. Your notified body (NB, the independent organisation that certifies your device for the EU market) or approved body (AB, the equivalent in the UK) will deal with you and your consultant by email, portal and video call much of the time. The only time your NB or AB will visit your site will be for audits - and some types of audits are conducted remotely anyway.
The remote-first reality of this profession predates the wider shift to remote working across the economy; regulatory consultants have worked at a distance from their clients, and from the bodies that assess them, for a long time. So if the ideal specialist for your device is hundreds or thousands of miles away, that is very rarely a problem worth worrying about.
What does a medical device regulatory consultant actually do?
Broadly, we help you get a device onto the market legally, and keep it there. In practice that means working out how your device is classified and which route to market applies; writing and reviewing the technical documentation and clinical evaluation that a notified body or approved body will assess; building or auditing your quality management system against ISO 13485; preparing the regulatory submission and dealing with the questions that come back; and, once the device is on the market, running post-market surveillance and vigilance so that problems in clinical use are picked up and acted on.
Very few consultants are equally strong across all of that, and across every device type. Most have a core — a handful of device categories they have taken through assessment many times — and a wider band of general competence around it. That is not a weakness; it is how the profession works, and it is exactly why device type and market experience matter more than anything else when you choose one.
That being said, if you are based in Scotland and looking for local support, what are your options?
Are there medical device regulatory consultants based in Scotland?
Yes — there are medical device regulatory consultancies based in Scotland, and Brightbark Cranberry is one of them. We specialise in non-active devices under EU MDR and UK MDR for deep technical work, and can work on more general aspects for other devices such as software, active devices and IVDs.
If you are a manufacturer or start-up based in Scotland, we can support you. However, most EU and UK regulatory work is done wherever the right expertise is, via modern digital communication. Technical files, clinical evaluations, and submissions are driven by documents and expertise, and are handled remotely as standard. So whilst we serve Scottish companies with a preference for local support, we also support manufacturers globally.
So what does a Scotland base actually offer?
- The same time zone. A UK-based consultant shares your working day, and works within the same business culture.
- Being in the room more regularly. Some work genuinely benefits from being in person - workshops, mock audits, training. A nearby consultant makes that easy and cheap, with the potential for more frequent face-to-face time.
- Familiarity with the local ecosystem. Scotland has a concentrated life-sciences and medtech community centred on its universities and innovation hubs — bodies such as the Medical Device Manufacturing Centre, Tay Health Tech, Scottish NHS Regional Innovation Hubs, and InnoScot Health. A consultant who knows that landscape understands the kind of company you are and the journey you are on.
Regulatory support for Scottish medtech start-ups and spinouts
That last point matters most for the innovators; founders of medtech start-ups and university spinouts coming out of Scotland's research base. If you are spinning a device out of Edinburgh, Glasgow, Strathclyde or Dundee, you are usually strong on the science and thin on the regulatory side — and the regulatory route is where a lot of value is won or lost.
Getting the regulatory direction right early — the classification, the route to market, the clinical evidence plan — is one of the most important things a spinout can do, because it shapes your timeline, your funding story, and how much of your value survives an investor's due diligence.
Brightbark Cranberry can support spinouts and early-stage manufacturers with:
- Early regulatory strategy advice.
- Ad-hoc advice and support for quality and regulatory topics.
- Full regulatory strategy documentation.
- Fractional leadership of QA & RA, until you are ready to hire someone full time.
- Writing procedures and technical documentation.
- Managing relationships with regulators and notified bodies.
Is there any regulatory role that has to be in the UK?
Yes, one — and it is worth being precise about it, because it is often confused with consultancy. If a manufacturer is established outside the UK and wants to place a device on the Great Britain market, it must appoint a UK Responsible Person. The UK Medical Devices Regulations 2002 define that role as a person established in the United Kingdom who acts on behalf of a manufacturer established outside the United Kingdom, and the MHRA will only accept device registrations from a UK-based manufacturer or from that manufacturer's UKRP. The EU has the mirror image: a manufacturer outside the EU needs an authorised representative established in the EU, under Article 11 of the EU MDR. So these two roles carry a genuine geographical requirement. It is a legal address, not a convenience.
That is a different thing from a consultant. A UKRP takes on defined legal responsibilities — registering your devices, holding copies of the declaration of conformity and technical documentation for the MHRA, being the point of contact for incidents and complaints. A consultant advises and writes. The two can be the same company, but they do not have to be, and hiring a Scottish consultant does not give you a UK Responsible Person unless you have appointed one in writing. If you are an overseas manufacturer looking at the UK, that is the one point where our Scottish address stops being a convenience and becomes something you can actually use.
How to choose — location as one factor among the real ones
If you are weighing up consultants, put location where it belongs: a convenience factor, well below the things that actually determine whether someone can help you. Far more important is whether they have genuine experience in your market (EU MDR, UKCA, or elsewhere) and your device type, who will actually do your work (the person on the sales call is not always the person who writes your clinical evaluation), and whether they will put scope in writing and tell you honestly when something falls outside their expertise.
In practice, that means asking a few direct questions before you sign anything. You should ask these of anyone, including me:
- Which device types have you personally taken through a notified body or approved body? Not the firm — the person. A consultancy's brochure and its individual consultants can have quite different track records.
- Who will do my work, and will I speak to them? Ask for the name of the person who will write your clinical evaluation or technical file, not the name of the account lead.
- Will you put scope, exclusions and deliverables in writing? A consultant who will not define what is out of scope has not thought hard about what is in it.
- What happens when something is outside your expertise? The right answer includes a name — someone they would refer you to — rather than a reassurance that it will not come up.
- How do you charge, and what changes the price? Fixed price, day rate or retainer, and what triggers a variation. More on this below.
- Where have you seen submissions fail, and why? This is the assessor's-eye question. Someone who has watched technical files come apart under review will answer it in detail.
I would rather lose a contract on the first question than win it on my postcode.
My background is in orthopaedic and dental devices. Nearly seven years assessing devices at a leading notified body means I can comfortably and appropriately work across most non-active implantable and non-implantable devices. I do not have the expertise to conduct deep technical work for active, software or IVD devices, though I can help with general topics such as QMS design, risk management procedures, and routes to market.
Contact me if those are your device types; that is a far better reason to talk to me than my postcode. The Scottish base is simply a convenience I'm glad to offer the companies near me.
How do medical device regulatory consultants charge?
The status quo in this industry is the day rate. It suits the consultant, because it puts the risk of the work overrunning on the client, and it suits genuinely open-ended engagements where nobody can say at the outset how much there is to do.
Brightbark Cranberry is trying to change that where we can. Wherever the scope can be defined tightly enough to price, we offer a fixed price: a pre-submission review of your technical documentation, a regulatory strategy document, a gap assessment against EU MDR or UK MDR. A fixed price means the cost of my misjudging the work is mine, not yours. Alongside that we offer arrangements that flex with the stage you are at — fractional QA and RA leadership at a set monthly fee, and ad-hoc support for the phase where you have a question a week rather than a project. Day rates are still there for the work that genuinely cannot be scoped in advance, but they are the exception rather than the default. Whatever the arrangement, it goes in writing, with what is included and what is not.
What can you offer manufacturers not based in Scotland?
All of the same services, just remotely. In my time at a leading notified body, almost all of the technical documentation audits I delivered were remote, and I learned to get the job done over a screen. It’s not hard these days - meetings can be held on Teams, and files transferred via a range of secure services. Backup solutions are available for everything.
Brightbark Cranberry supports manufacturers globally. For UK and EU manufacturers, we can offer face-to-face meetings where it is desired, and regular on-site audit support. Further geographies can be supported fully remotely, with on site support on a case-by-case basis.
Frequently asked questions
Are there medical device regulatory consultants in Scotland?
Yes. There are medical device regulatory affairs consultants based in Scotland, including Brightbark Cranberry. Because the work is largely remote and expertise-driven, Scottish companies can also work easily with consultants elsewhere in the UK and the EU — so you are choosing from a wide field, not a short local list.
Does my regulatory consultant need to be in the same country as me?
No. EU MDR and UK regulatory work — technical documentation, clinical evaluation, submissions, audit support — is done remotely as standard, and dealings with your notified body or the MHRA do not depend on your consultant's location. Match on expertise first; treat location as a convenience.
Do I need a UK Responsible Person if I use a Scottish consultant?
Only if your company is established outside the UK and you want to place devices on the Great Britain market. A consultant is not a UK Responsible Person unless you have formally appointed them as one; the two roles are separate, even when the same company provides both.
What does a regulatory consultant do that my notified body won't?
Notified bodies assess; they are prohibited from consulting. Under EU MDR they must remain independent of the manufacturers they certify and cannot advise on how to design your quality system or write your technical documentation. A consultant does the preparatory and advisory work that the notified body is not allowed to do.
What should I ask a regulatory consultant before hiring them?
Which device types they have personally taken through assessment, who will actually do the work, whether scope and exclusions will be put in writing, what they do when a question falls outside their expertise, how they handle notified body or MHRA correspondence, and how they charge.
How much does a medical device regulatory consultant cost?
It depends on the device, the market and the state of your existing documentation, so any figure given without seeing those is a guess. The commercial model matters as much as the rate: day-rate work leaves overrun risk with you, fixed-price packages move it to the consultant. Brightbark Cranberry offers fixed prices wherever the scope can be defined, with flexible retainer and ad-hoc arrangements for ongoing support.
What are the advantages of a Scotland-based regulatory consultant for a Scottish start-up?
The same working day and culture, the practical option of in-person workshops, mock audits and training, and familiarity with the Scottish medtech and university-spinout ecosystem. Useful, but secondary to whether the consultant fits your device and market.
Can a Scottish medtech spinout get regulatory support without relocating?
Yes. Your regulatory strategy does not have to move with your search for capital. Setting the regulatory direction early — classification, route to market, clinical evidence — is achievable wherever you are based, and is one of the most valuable early investments a spinout can make.
If you are a Scottish medtech founder — or anywhere else in the UK or the EU — and you want a straight answer on your regulatory route, I'm glad to talk. Being based in Scotland means I can come and sit with your team when that helps; being an ex-notified-body assessor is the part that actually matters. You can read more about how I work and the regulatory affairs support I offer, or just get in touch.